Search - tctmd.com

Displaying 1 - 17 of 17

Sort: Relevancy | Date

News Conference News TCT 2021

FAVOR III China Adds Strength to Value of QFR-Guided PCI

L.A. McKeown

November 04, 2021

News Daily News

New Chest Pain Guidelines Out at Last: Most Tests Have a Role

Michael O'Riordan

October 28, 2021

News Conference News VIVA 2021

Vascular Care Falls Short Before Amputation for CLI: Medicare Analysis

L.A. McKeown

October 06, 2021

News Daily News

PAD Continues to Elude Clinicians, Despite Gains: AHA

L.A. McKeown

August 05, 2021

News Daily News

Periprocedural MIs Associated With PCI Prognostically Relevant: ESC/EAPCI

Michael O'Riordan

June 10, 2021

News Opinion Conversations in Cardiology

Conversations in Cardiology: Will Insurance Cover Cath in Asymptomatic Patients?

June 04, 2021

News Conference News EuroPCR 2021

FUTURE II: A Good ‘First Step’ for Thinner-Strut Bioresorbable Scaffold

Michael O'Riordan

May 19, 2021

News Conference News ACC 2021

Complete Revascularization Analysis of ISCHEMIA Opens ‘Pandora’s Box’

Michael O'Riordan

May 18, 2021

News Conference News ACC 2021

SAFE-PAD Throws More Doubt on the Paclitaxel Mortality Signal

L.A. McKeown

May 16, 2021

News Daily News

Critical Limb Ischemia During COVID: Lessons for Care and Clinical Trials

L.A. McKeown

April 26, 2021

News Daily News

Vascular Experts Say It’s Time to Let Paclitaxel Out of Regulatory Jail

L.A. McKeown

April 22, 2021

News Features

Virtual Training Booms as COVID-19 Limits In-Person Proctoring, Observation

Yael L. Maxwell

April 21, 2021

News Daily News

AHA Seeks to Drive Down Amputations 20% by 2030

L.A. McKeown

April 01, 2021

News Daily News

Invasive Approach Best for Cocaine-Linked NSTEMI, but DAPT Is Key

Michael O'Riordan

March 16, 2021

News Daily News

FDA Advisors Unconvinced by Lutonix BTK Drug-Coated Balloon

L.A. McKeown

February 18, 2021

News Daily News

No Paclitaxel Death Signal in VA Data Out to 3 Years

L.A. McKeown

February 11, 2021

FDA Says Newer Paclitaxel Data Is ‘Comforting’ but Limited

News Daily News

FDA Says Newer Paclitaxel Data Are ‘Comforting’ but Limited

L.A. McKeown

January 12, 2021

Advertisement

FAVOR III China Adds Strength to Value of QFR-Guided PCI

New Chest Pain Guidelines Out at Last: Most Tests Have a Role

Vascular Care Falls Short Before Amputation for CLI: Medicare Analysis

PAD Continues to Elude Clinicians, Despite Gains: AHA

Periprocedural MIs Associated With PCI Prognostically Relevant: ESC/EAPCI

Conversations in Cardiology: Will Insurance Cover Cath in Asymptomatic Patients?

FUTURE II: A Good ‘First Step’ for Thinner-Strut Bioresorbable Scaffold

Complete Revascularization Analysis of ISCHEMIA Opens ‘Pandora’s Box’

SAFE-PAD Throws More Doubt on the Paclitaxel Mortality Signal

Critical Limb Ischemia During COVID: Lessons for Care and Clinical Trials

Vascular Experts Say It’s Time to Let Paclitaxel Out of Regulatory Jail

Virtual Training Booms as COVID-19 Limits In-Person Proctoring, Observation

AHA Seeks to Drive Down Amputations 20% by 2030

Invasive Approach Best for Cocaine-Linked NSTEMI, but DAPT Is Key

FDA Advisors Unconvinced by Lutonix BTK Drug-Coated Balloon

No Paclitaxel Death Signal in VA Data Out to 3 Years

FDA Says Newer Paclitaxel Data Are ‘Comforting’ but Limited

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content